This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sexual Function Improves Significantly After Hip Or Knee Replacement Surgery

More females report improvement

CHICAGO, March 19, 2013 /PRNewswire-USNewswire/ --  Osteoarthritis of the hip or knee, affecting millions of Americans each year, is known to limit sexual activity. New research presented today at the 2013 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) found that total hip (THR) or total knee replacement (TKR) surgery improves sexual function in 90 percent of patients.

In the study, 147 patients under age 70, scheduled for primary THR or TKR, agreed to participate in a study requiring the completion of questionnaires prior to surgery, at six months post surgery, and at one year post surgery.  Sixty-five percent of patients returned all three surveys. 

The group of patients included 68 men and 78 women with a mean age of 57.7 years.  Among the results:   

  • Sixty-seven percent of the patients reported physical problems with sexual activity prior to surgery – 67 percent pain; 36 percent, stiffness; 49 percent, reduced libido; and 14 percent, inability to attain proper position.
  • Ninety-one percent of participating patients reported psychological issues related to their osteoarthritis – 91 percent diminished general well being, and 53 percent, diminished sexual self image.

Following the surgery, 42 percent of patients reported an improvement in libido; 41 percent, increased intercourse duration; and 41 percent, increased intercourse frequency. Eighty-four percent of patients reported improvement in their general well being, and 55 percent in their sexual self image. Sixteen percent of patients reported that their joint replacement surgery adversely affected their sexual function, primarily due to a fear of damaging the replaced joint.

Overall, 90 percent of THR and TKR patients reported improved overall sexual function, with a slightly higher rate of improvement after THR than TKR.  More females reported improvement after THR than males.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs